*Q4 15 (and FY 15) misses “own” guidance* In line with the preliminary results announced on 10 January 2015, Qiagen reported weak Q4 15 and FY 15 numbers, with both top-line and bottom-line failing to meet the company’s own guidance given at the time of the Q3 15 results. Net sales were up 3% (all sales growth numbers at CER, unless otherwise specified) in both Q4 15 and FY 15, below management's guidance of 5% for Q4 15 and 4% for FY 15. While acquisitions contributed c.2pp
22 Feb 2016
Q4 15 misses guidance; forex, incremental investments to weigh on FY 16
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q4 15 misses guidance; forex, incremental investments to weigh on FY 16
*Q4 15 (and FY 15) misses “own” guidance* In line with the preliminary results announced on 10 January 2015, Qiagen reported weak Q4 15 and FY 15 numbers, with both top-line and bottom-line failing to meet the company’s own guidance given at the time of the Q3 15 results. Net sales were up 3% (all sales growth numbers at CER, unless otherwise specified) in both Q4 15 and FY 15, below management's guidance of 5% for Q4 15 and 4% for FY 15. While acquisitions contributed c.2pp